Anbio Biotechnology Class A Ordinary Shares
NASDAQ: NNNN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Michael Lau
- Employees
- 27
- Headquarters
- Frankfurt am Main, Germany
- IPO year
- 2025
- Market cap
- $669.3M
- Website
- https://www.anbio.com
Loading NNNN…
Loading profile data…Frequently asked questions about NNNN
What does Anbio Biotechnology Class A Ordinary Shares (NNNN) do?
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions,...
Where does NNNN trade?
Anbio Biotechnology Class A Ordinary Shares (NNNN) trades on the NASDAQ Global Select.
What sector is NNNN in?
Anbio Biotechnology Class A Ordinary Shares (NNNN) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Anbio Biotechnology Class A Ordinary Shares?
Michael Lau is the chief executive officer of Anbio Biotechnology Class A Ordinary Shares (NNNN).
Where is Anbio Biotechnology Class A Ordinary Shares headquartered?
Anbio Biotechnology Class A Ordinary Shares is headquartered in Germany.
Does NNNN pay a dividend?
Anbio Biotechnology Class A Ordinary Shares (NNNN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NNNN go public?
Anbio Biotechnology Class A Ordinary Shares (NNNN) completed its initial public offering in 2025.